Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

In memoriam Donald E. Gardner, PhD, ATS (1931-2014).

Naas LA, Graham JA, Holsapple MP, Miller FJ, Selgrade MJ.

J Immunotoxicol. 2015 Apr-Jun;12(2):104-5. doi: 10.3109/1547691X.2014.994285. Epub 2014 Dec 26. No abstract available.

PMID:
25541221
2.

Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program.

Juberg DR, Borghoff SJ, Becker RA, Casey W, Hartung T, Holsapple MP, Marty MS, Mihaich EM, Van Der Kraak G, Wade MG, Willett CE, Andersen ME, Borgert CJ, Coady KK, Dourson ML, Fowle JR 3rd, Gray LE, Lamb JC, Ortego LS, Schug TT, Toole CM, Zorrilla LM, Kroner OL, Patterson J, Rinckel LA, Jones BR.

ALTEX. 2014;31(1):63-78. doi: 10.14573/altex.1309171. Epub 2013 Oct 10.

3.

The new revolution in toxicology: the good, the bad, and the ugly.

Davis M, Boekelheide K, Boverhof DR, Eichenbaum G, Hartung T, Holsapple MP, Jones TW, Richard AM, Watkins PB.

Ann N Y Acad Sci. 2013 Mar;1278:11-24. doi: 10.1111/nyas.12086.

PMID:
23488558
4.

Juvenile immunotoxicology.

Holsapple MP, O'Lone R.

Toxicol Pathol. 2012;40(2):248-54. doi: 10.1177/0192623311427708. Epub 2012 Jan 17. Review.

PMID:
22252913
5.

Accelerating the development of 21st-century toxicology: outcome of a Human Toxicology Project Consortium workshop.

Stephens ML, Barrow C, Andersen ME, Boekelheide K, Carmichael PL, Holsapple MP, Lafranconi M.

Toxicol Sci. 2012 Feb;125(2):327-34. doi: 10.1093/toxsci/kfr248. Epub 2011 Sep 26.

6.

Human and environmental health challenges for the next decade (2010–2020).

Bonnefoi MS, Belanger SE, Devlin DJ, Doerrer NG, Embry MR, Fukushima S, Harpur ES, Hines RN, Holsapple MP, Kim JH, MacDonald JS, O'Lone R, Pettit SD, Stevens JL, Takei AS, Tinkle SS, van der Laan JW.

Crit Rev Toxicol. 2010 Nov;40(10):893-911. doi: 10.3109/10408444.2010.506640. Review.

PMID:
20854192
7.

Forum Series: the "Vision" for Toxicity Testing in the 21st Century: promises and conundrums.

Holsapple MP, Afshari CA, Lehman-McKeeman LD.

Toxicol Sci. 2009 Feb;107(2):307-8. doi: 10.1093/toxsci/kfn258. Epub 2008 Dec 9. No abstract available.

PMID:
19066395
8.

Interlaboratory study of the primary antibody response to sheep red blood cells in outbred rodents following exposure to cyclophosphamide or dexamethasone.

Loveless SE, Ladics GS, Smith C, Holsapple MP, Woolhiser MR, White KL Jr, Musgrove DL, Smialowicz RJ, Williams W.

J Immunotoxicol. 2007 Jul;4(3):233-8. doi: 10.1080/15476910701385687.

PMID:
18958733
9.

TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.

North CM, Kim BS, Snyder N, Crawford RB, Holsapple MP, Kaminski NE.

Toxicol Sci. 2009 Jan;107(1):85-92. doi: 10.1093/toxsci/kfn223. Epub 2008 Oct 22.

10.

Predicting future human and environmental health challenges: the Health and Environmental Sciences Institute's scientific mapping exercise.

Smith LL, Brent RL, Cohen SM, Doerrer NG, Goodman JI, Greim H, Holsapple MP, Lightfoot RM.

Crit Rev Toxicol. 2008;38(10):817-45. doi: 10.1080/10408440802486378 . Review.

PMID:
18853291
11.

Dose response considerations in risk assessment--an overview of recent ILSI activities.

Holsapple MP, Wallace KB.

Toxicol Lett. 2008 Aug 15;180(2):85-92. doi: 10.1016/j.toxlet.2008.05.020. Epub 2008 Jun 6. Review.

PMID:
18588961
12.

What's so special about the developing immune system?

Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP.

Int J Toxicol. 2008 Mar-Apr;27(2):223-54. doi: 10.1080/10915810801978110. Review.

PMID:
18404545
13.

Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative.

Thybaud V, Aardema M, Casciano D, Dellarco V, Embry MR, Gollapudi BB, Hayashi M, Holsapple MP, Jacobson-Kram D, Kasper P, MacGregor JT, Rees R.

Mutat Res. 2007 Oct 4;633(2):67-79. Epub 2007 May 24.

PMID:
17616430
14.

Evaluating emerging issues in epidemiology.

Collins JJ, Bukowski JA, Weed DL, Brent RL, Klein P, Boerstoel-Streefland M, Sprafka JM, Williams AL, Holsapple MP.

Regul Toxicol Pharmacol. 2007 Aug;48(3):296-307. Epub 2007 Apr 14.

PMID:
17543434
15.

Methodologies for developmental immunotoxicity (DIT) testing.

Dietert RR, Holsapple MP.

Methods. 2007 Jan;41(1):123-31. Review.

PMID:
17161309
16.

Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.

Luebke RW, Holsapple MP, Ladics GS, Luster MI, Selgrade M, Smialowicz RJ, Woolhiser MR, Germolec DR.

Toxicol Sci. 2006 Nov;94(1):22-7. Epub 2006 Aug 1.

17.

Assessing the potential to induce respiratory hypersensitivity.

Holsapple MP, Jones D, Kawabata TT, Kimber I, Sarlo K, Selgrade MK, Shah J, Woolhiser MR.

Toxicol Sci. 2006 May;91(1):4-13. Epub 2005 Dec 9. Review.

PMID:
16339788
18.

Mode of action in relevance of rodent liver tumors to human cancer risk.

Holsapple MP, Pitot HC, Cohen SM, Boobis AR, Klaunig JE, Pastoor T, Dellarco VL, Dragan YP.

Toxicol Sci. 2006 Jan;89(1):51-6. Epub 2005 Oct 12. Erratum in: Toxicol Sci. 2006 Apr;90(2):596. Cohen, Samuel H [corrected to Cohen, Samuel M].

PMID:
16221960
19.

Forum series: research strategies for safety evaluation of nanomaterials.

Holsapple MP, Lehman-McKeeman LD.

Toxicol Sci. 2005 Oct;87(2):315. No abstract available.

PMID:
16144823
20.

Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.

Holsapple MP, Farland WH, Landry TD, Monteiro-Riviere NA, Carter JM, Walker NJ, Thomas KV.

Toxicol Sci. 2005 Nov;88(1):12-7. Epub 2005 Aug 24.

PMID:
16120754
21.

Developmental toxicology evaluations--issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies.

Ladics GS, Chapin RE, Hastings KL, Holsapple MP, Makris SL, Sheets LP, Woolhiser MR, Burns-Naas LA.

Toxicol Sci. 2005 Nov;88(1):24-9. Epub 2005 Aug 24.

PMID:
16120748
22.

Cytokine mRNA profiles for isocyanates with known and unknown potential to induce respiratory sensitization.

Plitnick LM, Loveless SE, Ladics GS, Holsapple MP, Smialowicz RJ, Woolhiser MR, Anderson PK, Smith C, Selgrade MJ.

Toxicology. 2005 Feb 28;207(3):487-99.

PMID:
15664275
23.

Skf 525-A induces cocaine N-demethylase, ethoxyresorufin O-deethylase, and pentoxyresorufin O-dealkylase activities by induction of cytochrome p-450 2B in female B6C3F1 mice.

Jeong TC, Chang HW, Lee ES, Jeon TW, Jeong HG, Holsapple MP.

J Toxicol Environ Health A. 2004 Dec;67(23-24):1955-70.

PMID:
15513895
24.

A proposed testing framework for developmental immunotoxicology (DIT).

Holsapple MP, Burns-Naas LA, Hastings KL, Ladics GS, Lavin AL, Makris SL, Yang Y, Luster MI.

Toxicol Sci. 2005 Jan;83(1):18-24. Epub 2004 Sep 29.

PMID:
15456913
25.

Symposium summary: children's health risk--what's so special about the developing immune system?

Holsapple MP, Paustenbach DJ, Charnley G, West LJ, Luster MI, Dietert RR, Burns-Naas LA.

Toxicol Appl Pharmacol. 2004 Aug 15;199(1):61-70. Review.

PMID:
15289091
26.

Species comparison of anatomical and functional immune system development.

Holsapple MP, West LJ, Landreth KS.

Birth Defects Res B Dev Reprod Toxicol. 2003 Aug;68(4):321-34. Review.

PMID:
14666995
27.

Identifying airway sensitizers: cytokine mRNA profiles induced by various anhydrides.

Plitnick LM, Loveless SE, Ladics GS, Holsapple MP, Smialowicz RJ, Woolhiser MR, Anderson PK, Smith C, Selgrade MJ.

Toxicology. 2003 Dec 1;193(3):191-201.

PMID:
14599759
28.

Workshop overview: approaches to the assessment of the allergenic potential of food from genetically modified crops.

Ladics GS, Holsapple MP, Astwood JD, Kimber I, Knippels LM, Helm RM, Dong W.

Toxicol Sci. 2003 May;73(1):8-16. Epub 2003 Apr 15.

PMID:
12700419
29.

Developmental immunotoxicity testing: a review.

Holsapple MP.

Toxicology. 2003 Apr 1;185(3):193-203. Review.

PMID:
12581694
30.

Oral bioaccessibility of dioxins/furans at low concentrations (50-350 ppt toxicity equivalent) in soil.

Ruby MV, Fehling KA, Paustenbach DJ, Landenberger BD, Holsapple MP.

Environ Sci Technol. 2002 Nov 15;36(22):4905-11.

PMID:
12487316
31.

Developmental immunotoxicology and risk assessment: a workshop summary.

Holsapple MP.

Hum Exp Toxicol. 2002 Sep-Oct;21(9-10):473-8.

PMID:
12458903
32.

Autoimmunity by pesticides: a critical review of the state of the science.

Holsapple MP.

Toxicol Lett. 2002 Feb 28;127(1-3):101-9. Review.

PMID:
12052647
33.

Cytokine profiling for chemical sensitizers: application of the ribonuclease protection assay and effect of dose.

Plitnick LM, Loveless SE, Ladics GS, Holsapple MP, Selgrade MJ, Sailstad DM, Smialowicz RJ.

Toxicol Appl Pharmacol. 2002 Mar 15;179(3):145-54.

PMID:
11906244
34.

Preliminary study to test the feasibility of using a local lymph node type of approach to characterize respiratory allergens.

Goud SN, Anderson PK, Wiescinski CM, Stebbins KE, Landry TD, Holsapple MP.

Toxicol Mech Methods. 2002;12(3):181-94. doi: 10.1080/15376520208951155.

PMID:
20021172
36.

Influence of p53 zygosity on select sperm parameters of the mouse.

Marty MS, Singh NP, Holsapple MP, Gollapudi BB.

Mutat Res. 1999 Jun 1;427(1):39-45.

PMID:
10354500
38.

Cocaine-induced release of corticosterone mediates differential effects on T-helper1 and T-helper2 cell responses.

Kump DF, Stanulis ED, Holsapple MP, Conrad DH, Rosecrans JA.

Adv Exp Med Biol. 1998;437:189-98. No abstract available.

PMID:
9666271
39.
40.

Characterization of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in B6C3F1 and DBA/2 mice following single and repeated exposures.

Morris DL, Jeong HG, Jordan SD, Kaminski NE, Holsapple MP.

Arch Toxicol. 1998 Feb;72(3):157-68.

PMID:
9520139
41.
42.

Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone.

Stanulis ED, Jordan SD, Rosecrans JA, Holsapple MP.

Immunopharmacology. 1997 Aug;37(1):25-33.

PMID:
9285241
43.
44.

Role of corticosterone in the enhancement of the antibody response after acute cocaine administration.

Stanulis ED, Matulka RA, Jordan SD, Rosecrans JA, Holsapple MP.

J Pharmacol Exp Ther. 1997 Jan;280(1):284-91.

PMID:
8996208
45.

Evaluation of sex- and strain-dependency of cocaine-induced immunosuppression in B6C3F1 and DBA/2 mice.

Matulka RA, Jordan SD, Stanulis ED, Holsapple MP.

J Pharmacol Exp Ther. 1996 Oct;279(1):12-7.

PMID:
8858969
46.

Identification of functional aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator in murine splenocytes.

Williams CE, Crawford RB, Holsapple MP, Kaminski NE.

Biochem Pharmacol. 1996 Sep 13;52(5):771-80.

PMID:
8765475
47.

Alternations in splenocyte and thymocyte subpopulations in B6C3F1 mice exposed to cocaine plus diazinon.

Kump DF, Matulka RA, Burton GF, Jordan SD, Holsapple MP.

J Pharmacol Exp Ther. 1996 Jun;277(3):1477-85.

PMID:
8667213
48.
49.

Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.

Jeong TC, Jordan SD, Matulka RA, Stanulis ED, Park SS, Holsapple MP.

J Pharmacol Exp Ther. 1996 Mar;276(3):1257-65.

PMID:
8786558
50.

Molecular mechanisms of toxicant-induced immunosuppression: role of second messengers.

Holsapple MP, Karras JG, Ledbetter JA, Schieven GL, Burchiel SW, Davila DR, Schatz AR, Kaminski NE.

Annu Rev Pharmacol Toxicol. 1996;36:131-59. Review.

PMID:
8725385

Supplemental Content

Loading ...
Support Center